Trial intelligence / Profile preview

Effect of benzalkonium chloride eye drops on conjunctival bacterial flora in dry eye

2015-002507-28Phase 4Terminated

Sponsor
Medical University of Vienna
Start
Jun 2015
Modality
Small Molecules
Countries
1
01

Overview

Phase 4, single-arm trial of benzalkonium chloride in dry eye syndrome (DED), sponsored by Medical University of Vienna. Primary endpoint: Number of colony forming units in conjunctival bacterial culture. Started Jun 2015; status: terminated.

02

Drugs

benzalkonium chloride
03

Conditions

dry eye syndrome (DED)

Beyond the preview

Go deeper on 2015-002507-28.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2015-002507-28.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call